Brendan Hannah - 05 Dec 2025 Form 4 Insider Report for Quince Therapeutics, Inc. (QNCX)

Role
CBO, COO & CCO
Signature
/s/ Brendan Hannah
Issuer symbol
QNCX
Transactions as of
05 Dec 2025
Transactions value $
$25,012
Form type
4
Filing time
08 Dec 2025, 08:12:05 UTC
Previous filing
23 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hannah Brendan CBO, COO & CCO C/O QUINCE THERAPEUTICS, INC., 611 GATEWAY BLVD., SUITE 273, SOUTH SAN FRANCISCO /s/ Brendan Hannah 06 Dec 2025 0001929422

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QNCX Common Shares Options Exercise $1.25K +2.27K +0.68% $0.55 337K 05 Dec 2025 Direct
transaction QNCX Common Shares Options Exercise $23.8K +25.3K +7.51% $0.94 362K 05 Dec 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QNCX Employee Stock Option (Right to Buy) Options Exercise $0 -2.27K -4.79% $0.00 45.2K 05 Dec 2025 Common Shares 2.27K $0.55 Direct F1
transaction QNCX Employee Stock Option (Right to Buy) Options Exercise $0 -25.3K -11.24% $0.00 200K 05 Dec 2025 Common Shares 25.3K $0.94 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of 103,500 employee stock options on May 19, 2022, which vest over a four-year period, with 25% of the shares subject to the option vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments over the following three years.
F2 Represents grant of 225,000 employee stock options on February 2, 2023, which vest in equal monthly installments at a rate of 1/48th of the total number of shares on each monthly anniversary of the vesting commencement date of January 1, 2023, with full vesting on the fourth annual anniversary of the vesting commencement date.